Mechanical circulatory support in ACS with cardiogenic shock: where are we in 2024 - EuroPCR

In this #europcr 2024 interview, Alaide Chieffo and Gabor Toth discuss mechanical circulatory support in cardiogenic shock and myocardial infarction. They address the ECLS-SHOCK trial's lack of benefit from prophylactic ECMO, stressing improved patient selection and timing. They contrast this with the DanGer Shock study, where precise patient selection and early intervention led to positive outcomes. They emphasize how these findings can inform daily practice, focusing on patient selection, timing, and a multidisciplinary approach.
This video was filmed during #EuroPCR 2024.
See more videos here: www.pcronline.com/Cases-resou...
#cardiogenicshock
#ecmo
#acs
#myocardialinfarction